{"DataElement":{"publicId":"2534499","version":"1","preferredName":"Central Nervous System Neoplasm Histopathologic Grade Grade CNSHistologicGradeVD","preferredDefinition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type.","longName":"2534257v1.0:2534462v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2534257","version":"1","preferredName":"Central Nervous System Neoplasm Histopathologic Grade Grade","preferredDefinition":"Abnormal growth of cells that comprise the tissues of the central nervous system (brain and spinal cord), without designation of benign or malignant nature.:The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior_Describes how closely a cancer resembles normal tissue of its same type, and the cancer's probable rate of growth","longName":"2534177v1.0:2427327v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2534177","version":"1","preferredName":"Central Nervous System Neoplasm Histopathologic Grade","preferredDefinition":"Abnormal growth of cells that comprise the tissues of the central nervous system (brain and spinal cord), without designation of benign or malignant nature.:The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior","longName":"C9293:C18000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Nervous System Neoplasm","conceptCode":"C9293","definition":"A benign or malignant, primary or metastatic neoplasm that affects the brain, meninges, or spinal cord.  Representative examples of primary neoplasms include astrocytoma, oligodendroglioma, ependymoma, and meningioma.  Representative examples of metastatic neoplasms include carcinoma and leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Histologic Grade","conceptCode":"C18000","definition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"21203CE5-B636-3F8E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-31","endDate":null,"createdBy":"UMLLOADER_CAE","dateCreated":"2006-10-31","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2427327","version":"1","preferredName":"Grade","preferredDefinition":"Describes how closely a cancer resembles normal tissue of its same type, and the cancer's probable rate of growth","longName":"C18000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic Grade","conceptCode":"C18000","definition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05116195-EBA8-7341-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-09","modifiedBy":"ONEDATA","dateModified":"2005-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2222502","version":"1","preferredName":"UML DEFAULT CD","preferredDefinition":"Default Conceptual Domain for UML Loader","longName":"UML DEFAULT CD","context":"caCORE","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E53F3B-47A4-52D1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-04-29","modifiedBy":"DWARZEL","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"21204ACA-DE86-49EE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-31","endDate":null,"createdBy":"UMLLOADER_CAE","dateCreated":"2006-10-31","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Permission to Release DEC granted by primary curator in 8/2008.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2534462","version":"1","preferredName":"CNSHistologicGradeVD Grade","preferredDefinition":"Permissible values for CNSHistologicGradeVD_A position on a scale of intensity or amount or quality.","longName":"2534462v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"WHO I","valueDescription":"WHO Central Nervous System Grade I","ValueMeaning":{"publicId":"2581531","version":"1","preferredName":"WHO Central Nervous System Grade I","longName":"2581531","preferredDefinition":"Describes central nervous system tumors that are generally low malignancy, non-infiltrative, and slow growing. Often they can be cured by surgery alone and there is a good chance of long term survival.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"WHO Central Nervous System Grade 1","conceptCode":"C62394","definition":"Describes central nervous system tumors that are generally low malignancy, non-infiltrative, and slow growing. Often they can be cured by surgery alone and there is a good chance of long term survival.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0B88-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-31","endDate":null,"createdBy":"UMLLOADER_CAE","dateCreated":"2006-10-31","modifiedBy":"LEEB","dateModified":"2008-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21206930-F8E5-5F6D-E044-0003BA3F9857","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CAE","dateCreated":"2006-10-31","modifiedBy":"ONEDATA","dateModified":"2006-10-31","deletedIndicator":"No"},{"value":"WHO II","valueDescription":"WHO Central Nervous System Grade II","ValueMeaning":{"publicId":"2581532","version":"1","preferredName":"WHO Central Nervous System Grade II","longName":"2581532","preferredDefinition":"A suffix denoting the second person having the same complete name (first, middle, and family names).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"WHO Central Nervous System Grade 2","conceptCode":"C62395","definition":"Describes central nervous system tumors that are generally relatively slow growing and somewhat infiltrative. They may recur after treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0B89-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-31","endDate":null,"createdBy":"UMLLOADER_CAE","dateCreated":"2006-10-31","modifiedBy":"LEEB","dateModified":"2008-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21206930-F8F7-5F6D-E044-0003BA3F9857","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CAE","dateCreated":"2006-10-31","modifiedBy":"ONEDATA","dateModified":"2006-10-31","deletedIndicator":"No"},{"value":"WHO III","valueDescription":"WHO Central Nervous System Grade III","ValueMeaning":{"publicId":"2581533","version":"1","preferredName":"WHO Central Nervous System Grade III","longName":"2581533","preferredDefinition":"Describes central nervous system tumors that are generally malignant and infiltrative. They tend to recur after treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"WHO Central Nervous System Grade 3","conceptCode":"C62396","definition":"Describes central nervous system tumors that are generally malignant and infiltrative. They tend to recur after treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0B8A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-31","endDate":null,"createdBy":"UMLLOADER_CAE","dateCreated":"2006-10-31","modifiedBy":"LEEB","dateModified":"2008-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21206930-F909-5F6D-E044-0003BA3F9857","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CAE","dateCreated":"2006-10-31","modifiedBy":"ONEDATA","dateModified":"2006-10-31","deletedIndicator":"No"},{"value":"WHO IV","valueDescription":"WHO Central Nervous System Grade IV","ValueMeaning":{"publicId":"2581534","version":"1","preferredName":"WHO Central Nervous System Grade IV","longName":"2581534","preferredDefinition":"Describes central nervous system tumors that are generally highly malignant, show rapid and aggressive growth, widely infiltrative, and prone to necrosis. They often recur rapidly after treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"WHO Central Nervous System Grade 4","conceptCode":"C62397","definition":"Describes central nervous system tumors that are generally highly malignant, show rapid and aggressive growth, widely infiltrative, and prone to necrosis. They often recur rapidly after treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0B8B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-31","endDate":null,"createdBy":"UMLLOADER_CAE","dateCreated":"2006-10-31","modifiedBy":"LEEB","dateModified":"2008-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21206930-F91B-5F6D-E044-0003BA3F9857","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CAE","dateCreated":"2006-10-31","modifiedBy":"ONEDATA","dateModified":"2006-10-31","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2453188","version":"1","preferredName":"Grade","preferredDefinition":"A position on a scale of intensity or amount or quality.","longName":"C48309","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Grade","conceptCode":"C48309","definition":"A position on a scale of intensity or amount or quality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"0DDD1E7C-BBFA-66D1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"21206930-F8D2-5F6D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-31","endDate":null,"createdBy":"UMLLOADER_CAE","dateCreated":"2006-10-31","modifiedBy":"CHILLIJ","dateModified":"2015-10-13","changeDescription":"10/13/2015 removed upside down question mark from change note. jk 10/11/12 jc Released, associated with a released Model CDE.  Associated with CDE CS/CSI, added rep term.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2534075","version":"1.2","longName":"caTISSUE CAE","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812217","version":"1","longName":"edu.pitt.cabig.cae.domain.cns","context":"NCIP"}]}],"AlternateNames":[{"name":"edu.pitt.cabig.cae.domain.cns.CNSHistologicGrade.grade","type":"UML Qualified Attr","context":"NCIP"},{"name":"CNSHistologicGrade:grade","type":"UML Class:UML Attr","context":"NCIP"}],"ReferenceDocuments":[{"name":"Histologic grade","type":"Preferred Question Text","description":"Histologic grade","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"21206DDA-C287-6374-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-07","endDate":null,"createdBy":"UMLLOADER_CAE","dateCreated":"2006-10-31","modifiedBy":"REEVESD","dateModified":"2009-07-16","changeDescription":"Permission to Release CDE granted by primary curator, Linda Schmandt, in 8/2008","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}